📅 PUBMED DAILY TRIAGE — 2026-06-01

Window: 2026-05-31 09:00 UTC → 2026-06-01 09:00 UTC (CRDT) Topics scanned: 10 | Candidates evaluated: ~75 | Articles classified: 14 High priority: 4 | Standard: 10 | Low/archive: ~61 | Unsolicited finds: 1 (classified) Run status: ✅ SUCCESS

🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic

Novel therapeutics: immunotherapy, CAR-T, targeted therapy

TR-2026-06-01-001 / PMID 42218899 · Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous NSCLC (HARMONi-6): interim OS analysis · 9/10 🟠 NOVEL_TREATMENT

Lancet | Phase 3 RCT (n=532) | HR for death 0.66 (0.50–0.87); p=0.0017; mOS 27.9 vs 23.7 months — first Phase 3 OS confirmation for the PD-1+VEGF bispecific class in first-line squamous NSCLC.

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

TR-2026-06-01-002 / PMID 42219271 · The Impact of GLP-1-Based Therapies on CV Outcomes in Type 2 Diabetes: NMA · 8/10 🟢 NEAR_TERM_IMPLEMENTABLE

Diabetes Obes Metab | SR + NMA, 15 RCTs (n=97,173) | Class-level all-cause mortality, CV mortality, and MACE benefit confirmed; semaglutide, efpeglenatide, albiglutide had most favorable MACE profiles at agent level.

AI/ML in clinical diagnostics and imaging

Aging, longevity, and population health

TR-2026-06-01-003 / PMID 42218715 · StackAge: an ensemble-based clock for precise quantification of biological age using multi-omics data · 8/10 🟢 NEAR_TERM_IMPLEMENTABLE

Brief Bioinform | UK Biobank cohort (n=30,376) | Ensemble proteomics+metabolomics aging clock: r=0.93 with chronological age; AUC >0.90 for T2DM, Alzheimer's, CKD prediction; modifiable lifestyle accelerators identified.

TR-2026-06-01-004 / PMID 42218728 · Liver Aging Index: A Noninvasive Score for Liver Biological Aging and Liver-Related Outcomes in Multicohorts · 8/10 🔴 EARLY_CANCER_DETECTION

Aging Cell | Multi-cohort (CKB n=21,629 + NHANES n=3,412 + VCTE-Prognosis n=12,170; 16 global centers) | LAI outperforms chronological age for mortality (AUROC 0.76); genetically accelerated liver aging → liver cancer HR 7.82, cirrhosis HR 3.94.

🟢⚪ STANDARD (5–7) — Top by Topic

Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)

• TR-2026-06-01-006 / 42219247 · Longitudinal Changes in Transfusion Practice in MDS: Population Data-Linkage Study · 6/10 · Public Health | PLT-T ↑ post-2011 (5-aza era); n=7,043; Victoria state
• TR-2026-06-01-007 / 42219116 · The Role of Advanced Molecular Diagnostics in Informing Targeted Therapies for AML · 6/10 · Diagnostics | MD Anderson review; NGS, MRD, WGS integration in AML clinical management

Early cancer detection (liquid biopsy, ctDNA, cfDNA)

• TR-2026-06-01-008 / 42219540 · Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: SR + Meta-Analysis · 6/10 · Early Detection | Mean 5.9 kg pre-diagnosis weight loss; n=25,971; reference for early detection models (Sentinel find)

Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk

• TR-2026-06-01-005 / 42219273 · Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in DKD · 7/10 · Treatment Innovation | Triple combo (finerenone+RASi+SGLT2i): 47% proteinuria reduction, +1.31 eGFR slope; n=255
• TR-2026-06-01-009 / 42219264 · Effect of Canagliflozin Dose on Renal and CV Outcomes — CANVAS · 6/10 · Treatment Innovation | 100mg = 300mg for renal endpoints; both beat placebo; n=4,330
• TR-2026-06-01-011 / 42219226 · Semaglutide Injection in Indian Patients With T2DM: Phase III RCT · 5/10 · Treatment Innovation | Non-inferior to Ozempic; access implications for India; n=314

Aging, longevity, and population health

• TR-2026-06-01-014 / 42219485 · Functional Limitations and Loneliness in Middle-Aged and Older Adults · 4/10 · Public Health | Middle-aged (40-65) most vulnerable to social loneliness; n=3,984

Rare diseases with high unmet need

• TR-2026-06-01-012 / 42218735 · Orphan Designation for Drugs Approved in US and EU: Comparative Analysis · 5/10 · Drug Development | Only 40.4% of EU approvals received orphan designation vs 97.7% in US; n=344 approvals
• TR-2026-06-01-013 / 42219246 · Quantitative Muscle MRI in Classic Infantile and Late-Onset Pompe Patients · 5/10 · Diagnostics | Phenotype-specific MRI patterns; supports ERT monitoring; n=20

💡 UNSOLICITED FINDS

TR-2026-06-01-010 / PMID 42219534 · Chronic Opioid Use and Risk of Infections and Death in IBD: Nationwide Cohort · 6/10 🟡 UNDERSERVED_POPULATION

Inflamm Bowel Dis | Denmark nationwide cohort (n=51,844; 23 years) | COU → HR 1.74–1.93 for death and infection in CD and UC regardless of opioid strength; warrants prescriber vigilance.

(Pancreatic cancer weight loss meta-analysis, TR-008, also flagged unsolicited_find = true — captured via sentinel scan and matched to T3 watchlist)

📊 TODAY'S BREAKDOWN

By research category:

• Treatment Innovation: 5 (TR-001, TR-002, TR-005, TR-009, TR-011)
• Early Detection: 2 (TR-004, TR-008)
• Diagnostics: 3 (TR-003, TR-007, TR-013)
• Public Health: 3 (TR-006, TR-010, TR-014)
• Drug Development: 1 (TR-012)

By evidence maturity:

• Potentially Practice-Changing: 2 (TR-001, TR-002)
• Validated: 6 (TR-003, TR-004, TR-005, TR-006, TR-009, TR-011)
• Exploratory: 3 (TR-012, TR-013, TR-014)
• (Review — TR-007 classified as Validated for the review itself)

By watchlist topic (reviewed / kept / highest score):

By source type: peer_reviewed 14 | preprint 0

Topics with zero 8+ articles this run: Hematologic malignancies, CBC/ML, Early cancer detection, Precision oncology, Rare diseases

🔧 RUN NOTES

• No window expansion triggered — 14 classified records well above the 5-record threshold.
• PMID 42216561 deferred again (Br J Haematol, AML ICE criteria) — abstract still not available as supplied by publisher. Second consecutive deferral. If not available next run, recommend title-only classification at score cap ≤3.
• T2 (CBC/ML): Zero results for third consecutive run. Topic query tightening has not resolved this; recommend replacing with a broader hematology+ML query or monitoring via PubMed alert. No expansion triggered per policy (topic sparsity handled silently per spec).
• T8 (Aging) best run in recent history: 2 HIGH articles (StackAge PMID 42218715; Liver Aging Index PMID 42218728) — both large-cohort, multi-omics, validation studies. The humans[MeSH] filter continues to deliver clean results.
• T7 (Cardiovascular) high volume: 14 raw results; 4 classified. Several GLP-1 editorials/letters excluded (no abstract). Veterinary exclusion filter working.
• False positives excluded: PMID 42219448 (pearl millet AI), 42219396 (dental nerve AI), 42219541 (algae GWAS), 42219418 (companion dog aging), 42219457 (cardiac surgery anesthesia — AML abbreviation expansion).
• Rolling 7-day topics with zero HIGH articles: Hematologic malignancies (3 consecutive days), CBC/ML (ongoing), Rare diseases (3 consecutive days). T6 and T7/T8 consistently outperforming.